P

Inventor

DIMARCHI RICHARD D

US100 patents
⚠️ This page may combine multiple inventors who share the name “DIMARCHI RICHARD D”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

LILLY CO ELI

29 patents
US6191102B1Feb 20, 2001

Use of GLP-1 analogs and derivatives administered peripherally in regulation of obesity

LILLY CO ELI412 citations99
US5552524ASep 3, 1996

Anti-obesity proteins

LILLY CO ELI172 citations99
US5521283AMay 28, 1996

Anti-obesity proteins

LILLY CO ELI147 citations99
US5552523ASep 3, 1996

Anti-obesity proteins

LILLY CO ELI124 citations98
US5552522ASep 3, 1996

Anti-obesity proteins

LILLY CO ELI116 citations98
US5700662ADec 23, 1997

Process for preparing insulin analogs

LILLY CO ELI101 citations97
US5691309ANov 25, 1997

Anti-obesity proteins

LILLY CO ELI83 citations96
US5532336AJul 2, 1996

Anti-obesity proteins

LILLY CO ELI76 citations96
US5512549AApr 30, 1996

Glucagon-like insulinotropic peptide analogs, compositions, and methods of use

LILLY CO ELI449 citations96
US5304473AApr 19, 1994

A-C-B proinsulin, method of manufacturing and using same, and intermediates in insulin production

LILLY CO ELI120 citations96
US5719266AFeb 17, 1998

Anti-obesity proteins

LILLY CO ELI70 citations93
US4605513AAug 12, 1986

Process for inhibiting peptide carbamylation

LILLY CO ELI35 citations93
US5851995ADec 22, 1998

Anti-obesity proteins

LILLY CO ELI19 citations92
US5622932AApr 22, 1997

IGF-1 superagonists

LILLY CO ELI41 citations92
US5605886AFeb 25, 1997

Anti-obesity proteins

LILLY CO ELI32 citations92
US5594104AJan 14, 1997

Anti-obesity proteins

LILLY CO ELI46 citations92
US5580954ADec 3, 1996

Anti-obesity proteins

LILLY CO ELI47 citations92
US5574133ANov 12, 1996

Anti-obesity proteins

LILLY CO ELI33 citations92
US5569744AOct 29, 1996

Anti-obesity proteins

LILLY CO ELI37 citations92
US5569743AOct 29, 1996

Anti-obesity proteins

LILLY CO ELI33 citations92
US5567678AOct 22, 1996

Anti-obesity proteins

LILLY CO ELI36 citations92
US5563245AOct 8, 1996

Anti-obesity proteins

LILLY CO ELI32 citations92
US5563244AOct 8, 1996

Anti-obesity proteins

LILLY CO ELI32 citations92
US5563243AOct 8, 1996

Anti-obesity proteins

LILLY CO ELI33 citations92
US5559208ASep 24, 1996

Anti-obesity proteins

LILLY CO ELI43 citations92
US5554727ASep 10, 1996

Anti-obesity proteins

LILLY CO ELI39 citations92
US5525705AJun 11, 1996

Anti-obesity proteins

LILLY CO ELI34 citations92
US5567803AOct 22, 1996

Anti-obesity proteins

LILLY CO ELI32 citations91
US4617149AOct 14, 1986

Growth hormone release factor analogs

LILLY CO ELI49 citations90

DIMARCHI RICHARD D

10 patents
US8729017B2May 20, 2014

Glucagon/GLP-1 receptor co-agonists

DIMARCHI RICHARD D29 citations93
US8703701B2Apr 22, 2014

Glucagon/GLP-1 receptor co-agonists

DIMARCHI RICHARD D23 citations93
US8551946B2Oct 8, 2013

Glucagon antagonist-GIP agonist conjugates and compositions for the treatment of metabolic disorders and obesity

DIMARCHI RICHARD D17 citations93
US8450270B2May 28, 2013

Glucagon analogs exhibiting enhanced solubility and stability in physiological pH buffers

DIMARCHI RICHARD D37 citations93
US9018164B2Apr 28, 2015

Glucagon analogs exhibiting physiological solubility and stability

DIMARCHI RICHARD D16 citations92
US8778872B2Jul 15, 2014

Amide based glucagon superfamily peptide prodrugs

DIMARCHI RICHARD D34 citations92
US8546327B2Oct 1, 2013

Glucagon/GLP-1 receptor co-agonists

DIMARCHI RICHARD D26 citations92
US8338368B2Dec 25, 2012

Glucagon analogs exhibiting physiological solubility and stability

DIMARCHI RICHARD D18 citations92
US8697838B2Apr 15, 2014

Ester-based insulin prodrugs

DIMARCHI RICHARD D19 citations90
US8507428B2Aug 13, 2013

Glucagon analogs exhibiting GIP receptor activity

DIMARCHI RICHARD D24 citations90

AMBRX INC

4 patents
US8053560B2Nov 8, 2011

Modified human plasma polypeptide or Fc scaffolds and their uses

AMBRX INC40 citations96
US7919591B2Apr 5, 2011

Modified human plasma polypeptide or Fc scaffolds and their uses

AMBRX INC41 citations96
US8022186B2Sep 20, 2011

Modified human plasma polypeptide or Fc scaffolds and their uses

AMBRX INC20 citations92
US7939496B2May 10, 2011

Modified human growth horomone polypeptides and their uses

AMBRX INC25 citations92

CHO HO SUNG

2 patents
US8778880B2Jul 15, 2014

Human growth hormone modified at position 35

CHO HO SUNG25 citations92
US8143216B2Mar 27, 2012

Modified human growth hormone

CHO HO SUNG17 citations92

ARADIGM CORP

1 patent
US5888477AMar 30, 1999

Use of monomeric insulin as a means for improving the bioavailability of inhaled insulin

ARADIGM CORP143 citations99

(unassigned)

1 patent
US5514646AMay 7, 1996

Insulin analogs modified at position 29 of the B chain

256 citations98

SHEFFER JOSEPH

1 patent
US8618257B2Dec 31, 2013

Modified human plasma polypeptide or Fc scaffolds and their uses

SHEFFER JOSEPH32 citations94

UNIV INDIANA RES & TECH CORP

1 patent
US8900593B2Dec 2, 2014

Glucagon/GLP-1 receptor co-agonists

UNIV INDIANA RES & TECH CORP16 citations91

VIGNATI LOUIS

1 patent
US8975223B2Mar 10, 2015

Methods for treating metabolic disorders and obesity with a peptide comprising the amino acid sequence of SEQ ID No. 146

VIGNATI LOUIS38 citations90

Showing the top 50 of 100 patents by PatentIndex Score.